1. The past time-series ILI occurrences over the 5 weeks displayed a fluctuating but clear upward trend, with values of ['1162', '1017', '1079', '1171', '1320']. After an initial dip from 1162 (Week 41, 2020) to 1017 (Week 42, 2020), ILI occurrences steadily increased to 1320 by Week 45, 2020. This consistent rise in the latter weeks indicates escalating respiratory illness activity, which likely influenced the future increase to 1263 after 5 weeks. 

2. A positive correlation exists between the upward trajectory in past ILI occurrences (notably Weeks 44 and 45, 2020) and the future report of 1263 cases. The gradual increase evident in the later weeks of the past data suggests momentum in illness activity, which continued into the reported future period (Week 50, 2020). 

3. Outpatient visits for ILI showed a steady increase, rising incrementally from 1.2% (Week 41, 2020) to 1.5% (Week 45, 2020). This persistent growth in ILI-related healthcare visits highlights a growing trend in respiratory illnesses, contributing to the subsequent surge in future occurrences.  
Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) consistently surpassed epidemic thresholds, escalating from 7.2% (Week 41, 2020) to 8.9% (Week 45, 2020). This sustained elevation in PIC deaths reflects heightened respiratory illness activity, signaling the broader conditions leading to the reported future ILI rise.  
Impact on traditional ILI surveillance due to pandemic-driven shifts in healthcare-seeking behaviors, consistently noted across the weeks, undermined the accuracy of real-time ILI data. These disruptions likely delayed recognition of rising cases and influenced the observed future increase to 1263.  

4. In summary, the reported 1263 ILI occurrences (Week 50, 2020) can be attributed to the upward trend in ILI activity in Weeks 44 and 45, 2020, increasing outpatient ILI visits, elevated PIC mortality rates consistently exceeding epidemic thresholds, and pandemic-induced disruptions to healthcare-seeking and reporting systems. This combination of factors led to the observed future surge in ILI cases.